Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Eliminating senescent cells can prevent and reverse chemotherapy-induced peripheral neuropathy.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

EGFR signaling is crucial for skin and hair health, and targeting it could help treat skin diseases and cancer.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Erlotinib can cause hair loss and texture changes.

A rare nail bed cancer was successfully treated with no recurrence after 4 years.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

Melanoma cells lose their ability to form tumors when placed in a zebrafish embryo environment.

A rare case linked complete hair loss to both pancreas and gallbladder cancer.

Deregulation of stem cell function is central to the development of some cancers.

Basal cell carcinoma with matrical differentiation is a rare type linked to hair follicles, with .-catenin important for its development.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

Cells in hair die by breaking down their DNA and mitochondria as they form keratin.

Malignant melanoma is the deadliest skin cancer, while BCC is the most common but rarely spreads, and SCC is more aggressive than BCC.

Chemotherapy targets all dividing cells, causing side effects like nausea and hair loss.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Ovarian steroid cell tumors can mimic adrenal hyperplasia, and surgery can normalize hormone levels.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

Complete removal of scalp tumors is crucial, but malignant cases may recur or metastasize, requiring a multidisciplinary approach and close follow-up.

Lack of KSR1 stops certain skin tumors in mice.

A man had a non-cancerous, fast-growing skin lump on his arm that was removed with surgery.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Alkaloids show promise in treating cholangiocarcinoma by effectively targeting cancer cells.